Commitments and Contingencies (Additional Information) (Details) - Rewrite [Member] $ in Millions |
Dec. 31, 2024
USD ($)
|
|---|---|
| Business Acquisition, Contingent Consideration [Line Items] | |
| Contingent payments | $ 130.0 |
| Regulatory approval milestone contingent payment | 100.0 |
| Pre-specified research milestones contingent payment | $ 30.0 |
| X | ||||||||||
- Definition Pre specified research milestones contingent payment. No definition available.
|
| X | ||||||||||
- Definition Regulatory approval milestone contingent payment. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|